The ability to produce a desired favourable effect in treating or preventing the studied disease or condition.
The process of allocating a unique identifier to a Subject on entry into a Clinical Study after obtaining written Informed Consent.
European Medicines Agency (EMEA)
A decentralised body of the European Union with headquarters in London. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. The EMEA coordinates the evaluation and supervision of medicinal products throughout the European Union. The Agency brings together the scientific resources of the 25 EU Member States in a network of 42 national competent authorities.